Vascular Biogenics Ltd. (NASDAQ: VBLT) Featured in Virtual Coverage of the 33rd Annual ROTH Conference
Vascular Biogenics Ltd. (NASDAQ: VBLT), operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for areas of unmet need in cancer and immune/inflammatory indications. For more information, visit the company's website at www.vblrx.com To schedule a one-on-one meeting, please contact your ROTH representative. To view IBN’s virtual coverage of ROTH’s 33rd Annual Conference, visit https://ibn.fm/ROTH2021…